Regenxbio RGNX
NASDAQ RGNX
$7.53 +0.08 (+1.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regenxbio (RGNX) EV to CFO (2018 - 2022)

Updated

Regenxbio's (RGNX) EV to CFO was 4.39 for Q3 2022, up 20.1% from the prior quarter.

Analysis

Regenxbio (RGNX) EV to CFO (2018 - 2022) Analysis & Trends

Over the twelve months ended Sep 30, 2022, Regenxbio's EV to CFO came in at -2.84; for FY2021, it was 4.31.

  • By year, EV to CFO came in at 11.42 in FY2018.
  • Five-year quarterly EV to CFO spans a low of 3.66 in Q2 2022 and a high of 105.30 in Q1 2019.
  • Per Business Quant data, the three quarters before Q3 2022 came in at 3.66 (Q2 2022), 4.99 (Q1 2022) and 4.31 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Regenxbio 407.85 Mn -525.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 4.39
Jun 30, 2022 3.66
Mar 31, 2022 4.99
Dec 31, 2021 4.31
Mar 31, 2019 105.30
Dec 31, 2018 11.42
Sep 30, 2018 24.46
Jun 30, 2018 20.84
Mar 31, 2018 40.99
API Access

Regenxbio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=RGNX&period=max&api_key=YOUR_API_KEY